Results 151 to 160 of about 5,796 (217)

New Drugs: Palivizumab

Australian Prescriber, 1999
openaire   +1 more source

Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce. [PDF]

Open Forum Infect Dis
Manzoni P, Baraldi E, Midulla F, Claris O, Dessardo S, Heikkinen T, Thwaites R, Paes B, Carbonell-Estrany X, Dobryanskyy D, Cetinkaya M, Al Harbi AS, Kang JM, Goh Eng Neo A, Chi H, Sant'Anna G, Villa Guillén M, Mariani GL, Safadi MAP, Urzua S, Zar HJ, Goussard P, Rodgers-Gray B, Waghorne N, Sanchez Luna M.   +24 more
europepmc   +1 more source

Health economic evaluation of implementing a universal immunization program with nirsevimab compared to standard of care for the prevention of respiratory syncytial virus disease in Canadian infants. [PDF]

Hum Vaccin Immunother
Shin T, Lee JK, Kieffer A, Greenberg M, Wu J.   +4 more
europepmc   +1 more source

Molecular Surveillance Reveals <i>F</i>-Gene Mutations and Constrained <i>G</i>-Gene Evolution in Human Respiratory Syncytial Virus: Implications for Vaccine Efficacy in Saudi Arabia. [PDF]

Vaccines (Basel)
Farrag MA, Aziz IM, Almuqrin AM, Alkubaisi NA, Aljowaie RM, Alsaleh AN, Alanazi FN, Abdulmanea AA, Almajhdi FN.   +8 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant Protection. [PDF]

Pharmacoeconomics
Zeevat F, van der Pol S, Kieffer A, Postma MJ, Boersma C.   +4 more
europepmc   +1 more source

Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study. [PDF]

Pediatr Pulmonol
Domany KA, Mandelberg A, Burrack N, Golan-Tripto I, Masarweh K, Gur M, Rochman M, Be'er M, Prais D, Mor M, Opek MW, Nasrallah E, Megged O, Shatzman Steuerman R, Stein M, Steinberg Z, Shehadeh S, Glatman-Freedman A, Tasher D.   +18 more
europepmc   +1 more source

Enhancing Respiratory Syncytial Virus Immunoprophylaxis: Addressing Challenges Beyond Palivizumab in the Gulf Region. [PDF]

Oman Med J
Babar A.
europepmc   +1 more source

Cost-effectiveness of nirsevimab and maternal RSVpreF for preventing respiratory syncytial virus disease in infants across Canada. [PDF]

BMC Med
Bugden S, Mital S, Nguyen HV.
europepmc   +1 more source

Epidemiology of moderate-to-severe respiratory syncytial virus infections in children in subtropical Okinawa, Japan: a 4-year retrospective study. [PDF]

Trop Med Health
Fukuoka-Araki K, Araki K, Fukuoka H, Cho Y, Matayoshi K, Makiya T, Kinjo S, Yamashiro T.   +7 more
europepmc   +1 more source